Condition: Delivery Complication · Cesarean Delivery Affecting Fetus · Sponsor: Rambam Health Care Campus
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
This description comes directly from the study's public registry record.
Gal Bachar, MD · +97247771449 · g_bachar@rambam.health.gov.il
Always discuss trial participation with your own doctor first.
| Rambam medical health campus | Haifa, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06181396